Clincosm LogoSign in Get a demo

nonneoplastic condition

Showing 1 - 16 of 16
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lymphoma, Nonneoplastic Condition Trial in United States (bleomycin sulfate, filgrastim, ABVD regimen)

Completed
Has Results
  • Lymphoma
  • Nonneoplastic Condition
  • bleomycin sulfate
  • +11 more
  • Tucson, Arizona
  • +422 more
Aug 16, 2022

Blood and Tissue Samples From Aggressive Non-Hodgkin B-Cell

Completed
  • Lymphoma
  • Nonneoplastic Condition
  • polymerase chain reaction
  • laboratory biomarker analysis
  • La Jolla, California
  • +15 more
Aug 6, 2020

Anal Cancer, Tumor of Uncertain Malignant Potential, Nonneoplastic Condition Trial in United States (clinical observation,

Completed
Has Results
  • Anal Cancer
  • +3 more
  • clinical observation
  • infrared photocoagulation therapy
  • Los Angeles, California
  • +6 more
Jul 28, 2020

Anal Cancer, Nonneoplastic Condition, Precancerous Condition Trial in Los Angeles (Papanicolaou test)

Completed
  • Anal Cancer
  • +2 more
  • Papanicolaou test
  • Los Angeles, California
    UCLA
Jul 30, 2020

Blood Samples From HIV Infection and Stage III or Stage IV

Terminated
  • Lymphoma
  • Nonneoplastic Condition
  • DNA analysis
  • +2 more
  • Baltimore, Maryland
  • +1 more
Jul 28, 2020

Nonneoplastic Condition Trial in Italy (dexamethasone, prednisone, quality-of-life assessment)

Completed
  • Nonneoplastic Condition
  • Tricase, (le), Italy
  • +41 more
Feb 17, 2017

Blood and Tissue Samples From Epstein-Barr Virus-Positive

Completed
  • Lymphoma
  • Nonneoplastic Condition
  • DNA analysis
  • +9 more
  • (no location specified)
May 13, 2016

Cervical Cancer, Nonneoplastic Condition, Precancerous Condition Trial in Chennai (biological, genetic, other, procedure)

Completed
Has Results
  • Cervical Cancer
  • +2 more
  • quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine
  • +4 more
  • Chennai, India
    YRG Care
Feb 1, 2016

Human Papilloma Virus Infection in HIV-Positive Indian Sex With

Completed
  • Nonneoplastic Condition
  • Precancerous Condition
  • DNA analysis
  • +5 more
  • San Francisco, California
    UCSF Helen Diller Family Comprehensive Cancer Center
Oct 1, 2015

Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial (drug, genetic, other, procedure)

Completed
  • Chronic Myeloproliferative Disorders
  • +6 more
  • (no location specified)
Jun 3, 2015

Nonneoplastic Condition Trial in Rochester (Rituximab, Prednisone)

Completed
  • Nonneoplastic Condition
  • Rochester, Minnesota
    Mayo Clinic
Oct 15, 2014

Nonneoplastic Condition Trial in United Kingdom (biological, drug, other, procedure)

Unknown status
  • Nonneoplastic Condition
  • anti-thymocyte globulin
  • +11 more
  • Birmingham, England, United Kingdom
  • +12 more
Sep 16, 2013

GVHD, Nonneoplastic Condition Trial in Birmingham (biological, drug, genetic, procedure, radiation)

Unknown status
  • Graft Versus Host Disease
  • Nonneoplastic Condition
  • adoptive immunotherapy
  • +10 more
  • Birmingham, England, United Kingdom
    Queen Elizabeth Hospital at University Hospital of Birmingham NH
Aug 23, 2013

Nonneoplastic Condition Trial in Duarte (PADRE-CMV fusion peptide vaccine, tetanus-CMV fusion peptide vaccine, agatolimod

Completed
  • Nonneoplastic Condition
  • PADRE-CMV fusion peptide vaccine
  • +2 more
  • Duarte, California
    City of Hope Comprehensive Cancer Center
Jun 21, 2012

Nonneoplastic Condition Trial run by the CC (E1M184V peptide vaccine, incomplete Freund's adjuvant, sargramostim)

Completed
  • Nonneoplastic Condition
  • E1M184V peptide vaccine
  • +3 more
  • Bethesda, Maryland
    Warren Grant Magnuson Clinical Center - NCI Clinical Trials Refe
May 1, 2012

Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial run by the CC (tanespimycin)

Completed
  • Chronic Myeloproliferative Disorders
  • +4 more
  • Bethesda, Maryland
  • +1 more
Mar 14, 2012